{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:11:40Z","timestamp":1790820700506,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Isaac Foundation"},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000871","name":"Newlife Foundation for Disabled Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0172435","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T21:33:32Z","timestamp":1487280812000},"page":"e0172435","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II"],"prefix":"10.1371","volume":"12","author":[{"given":"H\u00e9l\u00e8ne F. E.","family":"Gleitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Holley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-1112","authenticated-orcid":false,"given":"Brian W.","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"ref1","unstructured":"Online Mendelian Inheritance in Man, OMIM\u00ae [database on the Internet]. 17\/10\/2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/omim.org\/\" xlink:type=\"simple\">http:\/\/omim.org\/<\/ext-link>."},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"F Baehner","year":"2005","journal-title":"Journal of inherited metabolic disease"},{"issue":"1\u20132","key":"ref3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"BJ Poorthuis","year":"1999","journal-title":"Human genetics"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"JE Wraith","year":"2008","journal-title":"European journal of pediatrics"},{"key":"ref5","unstructured":"Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In: McGraw-Hill, editor. Lysosomal Disorders2001. p. 3421\u201352."},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of Hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"M Cardone","year":"2006","journal-title":"Human molecular genetics"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"PJ Meikle","year":"1999","journal-title":"Jama"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"E1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural Progression of Neurological Disease in Mucopolysaccharidosis Type II","volume":"127","author":"JB Holt","year":"2011","journal-title":"Pediatrics"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ymgme.2007.08.034","article-title":"Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome)","volume":"92","author":"C Eng","year":"2007","journal-title":"Molecular genetics and metabolism"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"J Muenzer","year":"2006","journal-title":"Genetics in Medicine"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"J Muenzer","year":"2011","journal-title":"Genetics in Medicine"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","article-title":"Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder","volume":"9","author":"DA Brooks","year":"2003","journal-title":"Trends in molecular medicine"},{"issue":"19","key":"ref13","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"JJ Boelens","year":"2013","journal-title":"Blood"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"RF Wynn","year":"2009","journal-title":"The Journal of pediatrics"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"M Aldenhoven","year":"2015","journal-title":"Blood"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"N Guffon","year":"2009","journal-title":"The Journal of pediatrics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"A Vellodi","year":"1999","journal-title":"Journal of inherited metabolic disease"},{"key":"ref18","article-title":"Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II","author":"T Wakabayashi","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"S Motas","year":"2016","journal-title":"JCI Insight"},{"key":"ref20","article-title":"Delivery of an adeno-associated virus vector into CSF attenuates central nervous system disease in mucopolysaccharidosis type II mice","author":"C Hinderer","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"ED Kakkis","year":"2001","journal-title":"Molecular genetics and metabolism"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbr.2010.01.045","article-title":"Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB","volume":"209","author":"MM Canal","year":"2010","journal-title":"Behavioural brain research"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-015-9126-5","article-title":"Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"7","author":"RA Mumford","year":"2015","journal-title":"J Neurodev Disord"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"e25717","DOI":"10.1371\/journal.pone.0025717","article-title":"Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test","volume":"6","author":"A Langford-Smith","year":"2011","journal-title":"PloS one"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1601-183X.2011.00706.x","article-title":"Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments","volume":"10","author":"A Langford-Smith","year":"2011","journal-title":"Genes, brain, and behavior"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/brain\/awu355","article-title":"Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model","volume":"138","author":"C Martins","year":"2015","journal-title":"Brain: a journal of neurology"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ymgme.2015.02.008","article-title":"Quantifying behaviors of children with Sanfilippo syndrome: The Sanfilippo Behavior Rating Scale","volume":"114","author":"EG Shapiro","year":"2015","journal-title":"Molecular genetics and metabolism"},{"issue":"439","key":"ref28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"J Muenzer","year":"2002","journal-title":"Acta paediatrica"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome)","volume":"30","author":"AR Garcia","year":"2007","journal-title":"Journal of inherited metabolic disease"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2015.02.006","article-title":"Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells","volume":"76","author":"L Jiang","year":"2015","journal-title":"Neurobiology of disease"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuroscience.2007.03.051","article-title":"Phenotypic characterization of spatial cognition and social behavior in mice with &apos;knockout&apos; of the schizophrenia risk gene neuregulin 1","volume":"147","author":"CMP O'Tuathaigh","year":"2007","journal-title":"Neuroscience"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2014.06.028","article-title":"Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1","volume":"277","author":"C O'Leary","year":"2014","journal-title":"Neuroscience"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1101\/lm.89805","article-title":"Working memory deficits in retinoid X receptor gamma-deficient mice","volume":"12","author":"M Wietrzych","year":"2005","journal-title":"Learn Memory"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","article-title":"Thigmotaxis as an Index of Anxiety in Mice\u2014Influence of Dopaminergic Transmissions","volume":"61","author":"P Simon","year":"1994","journal-title":"Behavioural brain research"},{"issue":"24","key":"ref35","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1093\/hmg\/ddq420","article-title":"Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy","volume":"19","author":"VA Polito","year":"2010","journal-title":"Human molecular genetics"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-001-0979-9","article-title":"Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory","volume":"160","author":"PM Wall","year":"2002","journal-title":"Psychopharmacology"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuron.2006.09.023","article-title":"Modeling madness in mice: One piece at a time","volume":"52","author":"PA Arguello","year":"2006","journal-title":"Neuron"},{"issue":"1\u20132","key":"ref38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2012.05.005","article-title":"Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II","volume":"107","author":"T Higuchi","year":"2012","journal-title":"Molecular genetics and metabolism"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2214.1981.tb00838.x","article-title":"Psychosocial problems in Hunter&apos;s syndrome","volume":"7","author":"ID Young","year":"1981","journal-title":"Child: care, health and development"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","article-title":"Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders","volume":"36","author":"EM Cross","year":"2013","journal-title":"Journal of inherited metabolic disease"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2016.01.048","article-title":"Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson&apos;s disease: Involvement of the dopamine system","volume":"616","author":"Z Guo","year":"2016","journal-title":"Neuroscience letters"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington&apos;s disease mutation","volume":"19","author":"RJ Carter","year":"1999","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1034\/j.1601-183X.2003.00028.x","article-title":"Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod","volume":"2","author":"MP McFadyen","year":"2003","journal-title":"Genes Brain and Behavior"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2990.1988.tb00891.x","article-title":"Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study","volume":"14","author":"I Ferrer","year":"1988","journal-title":"Neuropathology and applied neurobiology"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10571-008-9335-5","article-title":"Alterations in oxidative markers in the cerebellum and peripheral organs in MPS I mice","volume":"29","author":"GK Reolon","year":"2009","journal-title":"Cellular and molecular neurobiology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"V4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"J Muenzer","year":"2011","journal-title":"Rheumatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0172435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T09:07:41Z","timestamp":1658653661000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0172435"}},"subtitle":[],"editor":[{"given":"Stephen D","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0172435","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}